1. Yang, Yang, Zhang, Minghui, Zhao, Yaxuan, Tian, Geng, Zhang, Yin. 2023. HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression. In Cancer science, 114, 4583-4595. doi:10.1111/cas.15982. https://pubmed.ncbi.nlm.nih.gov/37752684/
2. Saraymen, Esma, Erdem, Yakut, Akalın, Hilal, Çetin, Mustafa, Özkul, Yusuf. 2024. Evaluation of HOTAIR, HOXD8, HOXD9, HOXD11 gene expression levels in Turkish patients with acute and chronic myeloid leukemia: A single center experience. In Cellular and molecular biology (Noisy-le-Grand, France), 70, 39-45. doi:10.14715/cmb/2024.70.11.5. https://pubmed.ncbi.nlm.nih.gov/39707783/
3. Zheng, Di, Ning, Jinzhuo, Xia, Yuqi, Ruan, Yuan, Cheng, Fan. 2022. Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance. In Frontiers in oncology, 12, 1008714. doi:10.3389/fonc.2022.1008714. https://pubmed.ncbi.nlm.nih.gov/36387262/
4. Loi, Eleonora, Zavattari, Cesare, Tommasi, Alessandro, Scartozzi, Mario, Zavattari, Patrizia. 2022. HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples. In British journal of cancer, 126, 1783-1794. doi:10.1038/s41416-022-01738-1. https://pubmed.ncbi.nlm.nih.gov/35177798/
5. Wen, Xiaoyun, Chen, Yu, Fang, Xiansong. 2021. Overexpression of HOXD8 inhibits the proliferation, migration and invasion of breast cancer cells by downregulating ILP2 expression. In Experimental and therapeutic medicine, 22, 1006. doi:10.3892/etm.2021.10439. https://pubmed.ncbi.nlm.nih.gov/34345288/
6. Mansour, Mohammed A, Senga, Takeshi. 2017. HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer. In The international journal of biochemistry & cell biology, 88, 1-13. doi:10.1016/j.biocel.2017.04.011. https://pubmed.ncbi.nlm.nih.gov/28457970/
7. Dareng, Eileen O, Coetzee, Simon G, Tyrer, Jonathan P, Pharoah, Paul D P, Gayther, Simon A. 2024. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. In American journal of human genetics, 111, 1061-1083. doi:10.1016/j.ajhg.2024.04.011. https://pubmed.ncbi.nlm.nih.gov/38723632/
8. Yu, Ke, Meng, Jiawei, Chen, Tiange, Huang, Tianxiang, Gao, Ge. 2025. HOXD8 drives Glioma progression through epithelial-mesenchymal transition regulation: Implications for prognosis and targeted therapy. In Experimental cell research, 446, 114476. doi:10.1016/j.yexcr.2025.114476. https://pubmed.ncbi.nlm.nih.gov/39978718/
9. Meng, Liwei, Xing, Zhaoquan, Guo, Zhaoxin, Liu, Zhaoxu. 2020. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. In Cell death & disease, 11, 1063. doi:10.1038/s41419-020-03236-9. https://pubmed.ncbi.nlm.nih.gov/33311496/
10. Feng, Yaling, Wang, Jianxia, He, Yue, Cao, Dandan, Wang, Aiping. 2019. HOXD8/DIAPH2-AS1 epigenetically regulates PAX3 and impairs HTR-8/SVneo cell function under hypoxia. In Bioscience reports, 39, . doi:10.1042/BSR20182022. https://pubmed.ncbi.nlm.nih.gov/30626726/
智鼠故事 
